Effects of standardized hydro-alcoholic extract of Vaccinium arctostaphylos leaf on hypertension and biochemical parameters in hypertensive hyperlipidemic type 2 diabetic patients: a randomized, double-blind and placebo-controlled clinical trial

Document Type: Original Research Article

Authors

1 Medicine, Quran and Hadith Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

2 Medicinal Plants Research Center, Institute of Medicinal Plants,ACECR, Karaj, Iran.

3 Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.

4 Institute of Medicinal Plants (ACECR)

Abstract

Objective: To study the blood pressure, lipid and glycemic effects and safety of Vaccinium arctostaphylos leaf in the hypertensive hyperlipidemic type 2 diabetic patients.
Materials and Methods: The patients took 350 mg standardized plant leaf hydro-alcoholic extract capsule (n=50) or placebo capsule (n=50) three times daily alongside conventional drugs for 2 months. At the baseline and endpoint, systolic and diastolic blood pressures and blood levels of fasting glucose (FG), 2-hr postprandial glucose (2hPPG), glycosylated hemoglobin (HbA1c), total cholesterol (TC), LDL-C, triglyceride, HDL-C, SGOT, SGPT and creatinine were determined in both groups. To evaluate the extract safety, serum SGOT, SGPT and creatinine levels were tested; also, the patients were requested to report any adverse effects.  
Results: FG, 2hPPG, HbA1c, TC, LDL-C, triglyceride and systolic and diastolic blood pressures were decreased, whereas HDL-C was increased significantly in the extract group compared to those of the placebo group at the endpoint (for all cases, p<0.05). The extract did not significantly influence other parameters and no adverse effects were reported.
Conclusion: V. arctostaphylosleaf hydro-alcoholic extract as an adjunct to the conventional drugs has additional antihypertensive as well as anti-dyslipidemic and anti-hyperglycemic effects in hypertensive hyperlipidemic type 2 diabetic patients. Besides, the extract lacks hepatic, renal and patient-reported adverse effects.  

Keywords

Main Subjects


Abidov M, Ramazanov A, Jimenez Del Rio M, Chkhikvishvili I. 2006. Effect of Blueberin on fasting glucose, C-reactive protein and plasma aminotransferases, in female volunteers with diabetes type 2: double-blind, placebo-controlled clinical study. Georgian Med News, 141: 66-72.  

Chrysant SG, Chrysant GS. 2017. Herbs used for the treatment of hypertension and their mechanism of action. Curr Hypertens Rep, 19: 77-86.

Feshani AM, Kouhsari SM, Mohammadi S. 2011. Vaccinium arctostaphylos,a common herbal medicine in Iran: molecular and biochemical study of its anti-diabetic effects on alloxan-diabetic Wistar rats. J Ethnopharmacol, 133: 67-74.

GBD 2015 Mortality and Causes of Death Collaborators. 2016. Global, regional, and national life expectancy, all-cause mortality and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388: 1459-1544.

Gutfinger T. 1981. Polyphenols in olive oils. J Am Oil Chem Soc, 58: 966-968.

Haddad PS, Eid HM. 2017. The anti-diabetic potential of quercetin: underlying mechanisms. Curr Med Chem, 24: 355-364.

Iranian Herbal Pharmacopoeia Commission. 2002. Iranian Herbal Pharmacopoeia. Ministry of Health, Treatment and Medical Education: Tehran; 575.

Katsiki N, Kolovou G, Perez-Martinez P, Mikhailidis DP. 2018. Dyslipidemia in the elderly: to treat or not to treat? Expert Rev Clin Pharmacol, 11: 259-278.

Khalili A, Khosravi MB, Nekooeian AA. 2011. The effects of aqueous extract of Vaccinium arctostaphylos leaves on blood pressure in renal hypertensive rats. Iran Red Crescent Med J, 13: 123-127.

Khonche A, Fallah Huseini H, Abdi H, Mohtashami R, Nabati F, Kianbakht S. 2017.Efficacy of Mentha pulegium extract in the treatment of functional dyspepsia: a randomized double-blind placebo-controlled clinical trial. J Ethnopharmacol, 206: 267-273.

Kianbakht S, Abasi B, Hashem Dabaghian F. 2013. Anti-hyperglycemic effect of Vaccinium arctostaphylos in type 2 diabetic patients. Forsch Komplementmed, 20: 17-22.

Kianbakht S, Abasi B, Hashem Dabaghian F. 2014. Improve lipid profile in hyperlipidemic patients taking Vaccinium arctostaphylos fruit hydro-alcoholic extract: A randomized double-blind placebo-controlled clinical trial. Phytother Res, 28: 432-436.

Larsen JR, Dima L, Correll CU. 2018. The pharmacological management of metabolic syndrome. Expert Rev Clin Pharmacol, 11: 397-410.

Lupsa BC, Inzucchi SE. 2018. Diabetes medications and cardiovascular disease: at long last progress. Curr Opin Endocrinol Diabetes Obes, 25: 87-93.

Mozaffarian V. 2013. Identification of medicinal and aromatic plants of Iran. Farhang Moaser: Tehran; 391-392.

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB. 2016. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation, 133: e38-360.

Naveed M, Hejazi V, Abbas M, Kamboh AA, Khan GJ, Shumzaid M, Ahmad F, Babazadeh D, FangFang X, Modarresi-Ghazani F, WenHua L, XiaoHui Z. 2018. Chlorogenic acid (CGA): a pharmacological review and call for further research. Biomed Pharmacother, 97: 67-74.

Nickavar B, Amin G. 2011. Enzyme assay guided isolation of an α-amylase inhibitor flavonoid from Vaccinium arctostaphylos leaves. Iran J Pharm Res, 10: 849-853.

Soltani R, Hakimi M, Asgary S, Ghanadian SM, Keshvari M, Sarrafzadegan N. 2014. Evaluation of the effects of Vaccinium arctostaphylos L. fruit extract on serum lipids and hs-CRP levels and oxidative stress in adult patients with hyperlipidemia: a randomized, double-blind, placebo-controlled clinical trial. Evid Based Complement Alternat Med, 2014: 217451-217456.

Verma N, Trehan N. 2013. HPLC analysis of methanolic extracts of herbs for quercetin content. J Pharmacognosy Phytochem, 2: 159-162.

Wen J, Kang L, Liu H, Xiao Y, Zhang X, Chen Y. 2012. A validated UV-HPLC method for determination of chlorogenic acid in Lepidogrammitis drymoglossoides (Baker) Ching, Polypodiaceae. Pharmacognosy Res, 4: 148-153.

Williamson G. 2017. The role of polyphenols in modern nutrition. Nutr Bull, 42: 226-235.

Yandrapalli S, Aronow WS. 2017. Cardiovascular benefits of the newer medications for treating type 2 diabetes mellitus. J Thorac Dis, 9: 2124-2134.